Stay updated on Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.

Latest updates to the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s technical release/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” without any change to the clinical trial information presented.SummaryDifference0.0%

- Check21 days agoChange DetectedAdded State of Vienna as a location and refined the Vienna address to Vienna, State of Vienna, Austria, 1160. Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved the 'Multiple myeloma' topic and the related 'MedlinePlus Genetics' topic from the page's related topics.SummaryDifference0.0%

- Check35 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics in the related topics section.SummaryDifference0.0%

- Check42 days agoChange DetectedBeijing, China (Beijing Municipality) with Peking Union Medical College Hospital was added; Genova, Italy added IRCCS Azienda Ospedaliera Metropolitana (IRCCS AOM). Removed entries include Beijing Peking Union Medical College Hospital and Genoa-related sites such as Ospedale San Martino and Liguria, with the total study locations changing to 238.SummaryDifference0.5%

- Check50 days agoChange DetectedAdded related topics 'Multiple myeloma' and 'MedlinePlus Genetics'. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.